ESS vs ITRM · P/E 31, rev $1.89B vs rev $390.0K
Essex Property Trust Inc (ESS) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the ESS and ITRM stock pages for the full models.
Not investment advice.